Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Thank you and see you in 2023

Grady Wulff
December 20, 2022

Weekly Wrap 16 December

Grady Wulff
December 16, 2022

Morning Bell 16 December

Bell Direct
December 16, 2022

Closing Bell 15 December

Grady Wulff
December 15, 2022

Morning Bell 15 December

Grady Wulff
December 15, 2022

Closing Bell 14 December

Grady Wulff
December 14, 2022

Morning Bell 14 December

Grady Wulff
December 14, 2022

Closing Bell 13 December

Grady Wulff
December 13, 2022

Morning Bell 13 December

Sophia Mavridis
December 13, 2022

Closing Bell 12 December

Grady Wulff
December 12, 2022

Morning Bell 12 December

Grady Wulff
December 12, 2022

Weekly Wrap 9 December

Grady Wulff
December 9, 2022